August 25, 2026 Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study
August 25, 2026 Five Trusted WPC Cladding Manufacturers in China 2026: Advancing Exterior Building Solutions